This inventor holds 10 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Oleofina, S.a., Smithkline Beecham Biologicals S.a.. Active years: 1987-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brussels, BE (1987 - 2006)
- Rixensart, BE (2000 - 2016)
Company Filing History:
3 out of 545 
3 out of 4 
2 out of 75 Years Active: 1987-2016
Title: Inventor Spotlight: Jean-Paul H. Prieels
Introduction
Jean-Paul H. Prieels is a prominent inventor based in Brussels, Belgium, known for his significant contributions to the field of immunology and vaccine development. With a remarkable portfolio of 10 patents, Prieels has dedicated his career to advancing healthcare innovations, particularly in the creation of vaccines.
Latest Patents
Among his latest patents, Jean-Paul H. Prieels has developed an inactivated dengue virus vaccine with an aluminium-free adjuvant. This innovation provides crucial immunogenic compositions aimed at preventing and treating diseases caused by the dengue virus. Additionally, he has contributed to the field of bacterial polysaccharide antigen vaccines, with his patent focusing on bacterial polysaccharides conjugated to protein D. This work represents significant advancements in vaccine technology and public health.
Career Highlights
Jean-Paul H. Prieels has built an impressive career in the pharmaceutical industry. He has been associated with notable companies such as Oleofina and GlaxoSmithKline Biologicals, where he applied his expertise in vaccine research and development. His dedication to innovation has positioned him as a leading figure in medical advancements.
Collaborations
Throughout his career, Prieels has collaborated with esteemed professionals in the field. Notable coworkers include Moncef Mohamed Slaoui, a prominent figure in vaccine development, and Charles Maschelein, enhancing the scope and impact of their combined efforts in immunology and public health.
Conclusion
Jean-Paul H. Prieels exemplifies the spirit of innovation in the life sciences sector. His contributions, particularly in vaccine development, showcase his commitment to combating infectious diseases and improving public health outcomes. As he continues to drive advancements in immunology, his work will undoubtedly have a lasting impact on future generations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile